Summary
Ten young women (mean age 22.5 years) were studied before and during treatment with a low dose oestrogen-progestogen oral contraceptive. Mean plasma cholesterol rose by a small but significant amount as did mean weight. However, there were varying individual responses to therapy. Mean triglyceride, low density lipoprotein cholesterol, high density lipoprotein cholesterol and very low density lipoprotein cholesterol did not change significantly. Thus it appears that any adverse effects on the vascular system of the newer low dose oestrogen-progestogen oral contraceptives cannot be explained in terms of their effects on plasma lipids.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Larsson-Cohn, U., Wallentin, L. and Zador, G. 1979. Plasma lipids and high density lipoproteins during oral contraception with different combinations of ethinyl estradiol and levonorgestrel. Horm. Metab. Res. 11, 437.
Rossner, S., Frankman, O. and Marsk, L. 1979. Effects of varous low dose contraceptive pills on serum lipoproteins.In: Lipoprotein Metabolism and Endocrine Regulation. L. Hessel and H. Krans. Elsevier/North Holland Biomedical Press, Amsterdom p. 91.
Rossner, S., Larsson-Cohn, U., Carlson, L. A. and Boberg, J. 1971. Effects of an oral contraceptive agent on plasma lipids, plasma lipoproteins, the intravenous fat tolerance, and the post heparin lipoprotein lipase activity. Acta. Med. Scand. 190, 301.
Taggart, H. and Stout, R. W. 1979. Reduced high density lipoprotein in stroke: relationship with elevated triglyceride and hypertension. Europ. J. Clin. Invest. 9, 219.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Taggart, H., Stout, R.W. Effect of a low dose estrogen-progestogen oral contraceptive on lipids and lipoproteins. I.J.M.S. 150, 13–14 (1981). https://doi.org/10.1007/BF02938186
Issue Date:
DOI: https://doi.org/10.1007/BF02938186